China Universal Asset Management »

Ovid Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $41k 14k 3.02
2023-12-31 $26k 8.2k 3.18
2022-09-30 $1.0k 660 1.52

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Ovid Therapeutics

BVF
EcoR1 Capital
Madison Avenue Partners
Vanguard Group
Artal Group
Jpmorgan Chase & Co
TLS Advisors
Blue Owl Capital Holdings
Wells Fargo & Company
Fft Wealth Management
Dimensional Fund Advisors
Bank of New York Mellon
Charles Schwab Investment Management
Assenagon Asset Management
Barclays

View all funds holding Ovid Therapeutics